Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony- stimulating factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors

Blood

Volumn 94, Issue 6, 1999, Pages 1943-1951

  Sun, Q ^a   Jones, K ^a   McClure, B ^a   Cambareri, B ^a   Zacharakis, B ^a   Iversen, P O ^a   Stomski, F ^a   Woodcock, J M ^a   Bagley, C J ^a   D'Andrea, R ^a   Lopez, A F ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BION 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIMERIZATION; EOSINOPHIL; EPITOPE MAPPING; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RECEPTOR BINDING;

EID: 0033568467     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.6.1943.418k04_1943_1951     Document Type: Article

References (58)

1. Bagley CJ, Woodcock JM, Stomski FC, Lopez AF: The structural and functional basis of cytokine receptor activation: Lessons from the common β subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3) and IL-5 receptors. Blood 89:1471, 1997
2. Lopez AF, Williamson DJ, Gamble JR, Begley CG, Harlan JM, Klebanoff SJ, Waltersdorph A, Wong G, Clark SC, Vadas MA: Recombinant human GM-CSF stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 78:1220, 1986
3. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA: Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 167:219, 1988
4. Sanderson CJ: Interleukin-5, eosinophils, and disease. Blood 79:3101, 1992
5. Rothenberg ME, Owen WF, Siberstein DS, Woods J, Soberman RJ, Austen KF, Stevens RL: Human eosinophils have prolonged survival, enhances functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest 81:1986, 1988
6. Begley CG, Lopez AF, Nicola NA, Warren DJ, Vadas MA, Sanderson CJ, Metcalf D: Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: A rapid and sensitive microassay for colony-stimulating factors. Blood 68:162, 1986
7. Owen WF, Rothenberg ME, Siberstein DS: Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med 166:129, 1987
8. Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, Bradley B, Durham SR, Collins JV, Jeffery PK: Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 87:1541, 1991
9. Saetta M, Di Stefano A, Maestrelli P, Turato G, Mapp CE, Pieno M, Zanguochi G, Del Prete G, Fabbri LM: Airway eosinophilia and expression of interleukin-5 protein in asthma and in excerbation of chronic bronchitis. Clin Exp Allergy 26:766, 1996
10. Sur S, Gleich GJ, Swanson MC, Bartemes KR, Broide DH: Eosinophilic inflammation is associated with elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma. J Allergy Clin Immunol 96:661, 1995
11. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q: Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/ macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 173:775, 1991
12. + T cell lines in atopic asthmatics, and atopic and non-atopic controls. Eur J Immunol 25:2727, 1995
13. Corrigan CJ, Hamid Q, North J, Barkans J, Moqbel R, Durham S, Gemou-Engesaeth V, Kay AB: Peripheral blood CD4 but not CD8 T-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: Effect of glucocorticoid therapy. Am J Respir Cell Mol Biol 12:567, 1995
14. Gibson PG, Zlatic K, Scott J, Sewell W, Woolley K, Saltos N: Chronic cough resembles asthma with IL-5 and granulocyte-macrophage colony-stimulating factor gene expression in bronchoalveolar cells. J Allergy Clin Immunol 101:320, 1998
15. Sousa AR, Lams BE, Pfister R, Christie PE, Schmitz M, Lee TH: Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatic airways. Am J Respir Crit Care Med 156:1384, 1997
16. Kobayashi T, Hashimoto S, Horie T: Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem Pharmacol 54:819, 1997
17. Lantero S, Sacco O, Scata C, Rossi GA: Stimulation of blood mononuclear cells of atopic children with the relevant allergen induces the release of eosinophil chemotaxins such as IL-3, IL-5 and GM-CSF. J Asthma 34:141, 1997
18. Shaver JR, Zangrilli JG, Cho S-K, Cirelli RA, Pollice M, Hastie AT, Fish JE: Kinetics of the development and recovery of the lung from IgE-mediated inflammation. Dissociation of pulmonary eosinophilia, lung injury, and eosinophil-active cytokines. Am J Crit Care Med 155:442, 1997
19. Miyajima A, Kinoshita T, Wakao H, Hara T, Yoshimura A, Nishinakamura R, Murray R, Mui A: Signal transduction by the GM-CSF, IL-3 and IL-5 receptors. Leukemia 11:418, 1997 (suppl 3)
20. Mauser PJ, Pitman AM, Fernandez X, Foran SK, Adams GK, Kreutner W, Egan RW, Chapman RW: Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 152:467, 1995
21. Kung TT, Stelts DM, Zurcher JA, Adams GK, Egan RW, Kreutner W, Watnick AS, Jones H, Chapman RW: Involvement of IL-5 in a murine model of allergic pulmonary inflammation: Prophylactic and therapy effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol 13:360, 1995
22. Hercus TR, Bagley CJ, Cambareri B, Dottore M, Woodcock JM, Vadas MA, Shannon MF, Lopez AF: Specific human granulocyte-macrophage colony-stimulating factor antagonists. Proc Natl Acad Sci USA 91:5838, 1994
23. Tavernier J, Tuypens T, Verhee A, Plaetinck G, Devos R, Van der Heyden J, Guisez Y, Oefner C: Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist. Proc Natl Acad Sci USA 92:5194, 1995
24. McKinnon M, Page K, Uings IJ, Banks M, Fattah D, Proudfoot AE, Graber P, Arod C, Fish R, Wells TN, Solari R: An interleukin 5 mutant distinguishes between two functional responses in human eosinophils. J Exp Med 186:121, 1997
25. Heaney ML, Golde DW: Soluble cytokine receptors. Blood 87:847, 1996
26. 21 of GM-CSF. EMBO J 13:5176, 1994
27. Woodcock JM, Bagley CJ, Zacharakis B, Lopez AF: A single tyrosine residue in the membrane proximal domain of the GM-CSF, IL-3 and IL-5 receptor common β chain is necessary and sufficient for high affinity binding and signalling by all three ligands. J Biol Chem 271:25999, 1996
28. Lock P, Metcalf D, Nicola NA: Histidine-367 of the human common beta chain of the receptor is critical for high-affinity binding of human granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci USA 91:252, 1994
29. D'Andrea RJ, Barry SC, Moretti PAB, Jones K, Ellis S, Vadas MA, Goodall GJ: Extracellular truncations of hβc, the common signaling subunit for interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-5, lead to ligand-independent activation. Blood 87:2641, 1996
30. 22, selectively interact with the α-and β-chains of its receptor and participate in function. J Biol Chem 269:8488, 1994
31. Vadas MA, David JR, Butterworth A, Pisani NT, Siongok TA: A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. J Immunol 122:1228, 1979
32. Elliott MJ, Vadas MA, Eglinton JM, Park LS, To LB, Cleland LG, Clark SC, Lopez AF: Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor show common biological effects and binding characteristics on human monocytes. Blood 74:2349, 1989
33. Sun Q, Woodcock JM, Rapoport A, Stomski FC, Korpelainen EI, Bagley CJ, Goodall GJ, Smith WB, Gamble JR, Vadas MA, Lopez AF: Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor α-chain and functions as a specific IL-3 receptor antagonist. Blood 87:83, 1996
34. Woodcock JM, McClure B, Stomski FC, Elliott MJ, Bagley CJ, Lopez AF: The human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor exists as a preformed receptor complex that can be activated by GM-CSF, interleukin-3, or interleukin-5. Blood 90:3005, 1997
35. Stomski FC, Sun Q, Bagley CJ, Woodcock JM, Goodall GJ, Andrews RK, Berndt MC, Lopez AF: Human interleukin-3 (IL-3) induces disulphide-linked receptor α and β chain heterodimerization which is required for receptor activation but not high affinity binding. Mol Cell Biol 16:3035, 1996
36. Contreras MA, Bale WF, Spar IL: Iodine monochloride (IC1) iodination techniques. Methods Enzymol 92:277, 1983
37. McConahey PJ, Dixon FJ: Radioiodination of proteins by the use of the chloramine-T method. Methods Enzymol 70:210, 1980
38. Lopez AF, Eglinton JM, Gillis D, Park LS, Vadas MA: Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils. Proc Natl Acad Sci USA 86:7022, 1989
39. Clutterbuck EJ, Hirst EMA, Sanderson CJ: Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood 73:1504, 1989
40. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
41. Walsh FS, Crumpton MJ: Orientation of cell-surface antigens in the lipid bilayer of lymphocyte plasma membrane. Nature 269:307, 1977
42. Hartnell A, Robinson DS, Kay AB, Wardlaw AJ: CD69 is expressed by human eosinophils activated in vivo in asthma by cytokines. Immunology 80:281, 1993
43. Stomski FC, Woodcock JM, Zacharakis B, Bagley CJ, Sun Q, Lopez AF: Identification of a Cys motif in the common β chain of the IL-3, GM-CSF and IL-5 receptors essential for disulfide-linked receptor hereodimerization and activation of all three receptors. J Biol Chem 273:1192, 1998
44. + T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 92:313, 1993
45. Allen JS, Eisma R, Leonard G, Kreutzer D: Interleukin-3 interleukin-5, and granulocyte-macrophage colony-stimulating factor expression in nasal polyps. Am J Otolaryngol 18:239, 1997
46. Gauvreau GM, O'Byrne PM, Moqbel R, Velazquez J, Watson RM, Howie KJ, Denburg JA: Enhanced expression of GM-CSF in differentiating eosinophils of atopic and atopic asthmatics subjects. Am J Respir Cell Mol Biol 19:55, 1998
47. Barat LT, Ying S, Meng Q, Barkans J, Rajakulasingam K, Durham SR, Kay AB: IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Allergy Clin Immunol 101:222, 1998
48. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326:298, 1992
49. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid Q: Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia. J Immunol 48:2390, 1992
50. Stampfli MR, Wiley RE, Scott Neigh G, Gajewska BU, Lei XF, Snider DP, Xing Z, Jordana M: GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice. J Clin Invest 102:1704, 1998
51. Lei XF, Ohkawara Y, Stampfli MR, Gauldie J, Croitoru K, Jordana M, Xing Z: Compartmentalized transgene expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation. Clin Exp Immunol 113:157, 1998
52. Hamilos DL, Leung DY, Wood R, Meyers A, Stephens JK, Barkans J, Meng Q, Cunningham L, Bean DK, Kay AB: Chronic hyperplastic sinusitis: Association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimluating factor and interleukin-3. J Allergy Clin Immunol 92:39, 1993
53. Zhang X, Ren R: Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: A novel model for chronic myelogenous leukemia. Blood 92:3829, 1998
54. Robb L, Drinkwater CC, Metcalf D, Li R, Kontgen F, Nicola NA, Begley CG: Hematopoietic and lung abnormalities in mice with a null mutation of the common β subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci USA 92:9565, 1995
55. Hagan JB, Kita H, Gleich GJ: Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: Comparison with other glucocorticoids. Clin Exp Allergy 28:999, 1998
56. Elliott MJ, Maini RN: Anti-cytokine therapy in rheumatoid arthritis. Clin Rheumatol 9:633, 1995
57. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD: Interleukin-13: Central mediator of allergic asthma. Science 282:2258, 1998
58. Grunig G, Warnock M, Wakil AE, Venkayya R, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, Corry DB: Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261, 1998